Arnold Ganser
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.1%
- Mesenchymal stem cell research
Papers in
- Hematology 671
- Acute Myeloid Leukemia Research 413
- Hematopoietic Stem Cell Transplantation 209
- Chronic Myeloid Leukemia Treatments 33
- Oncology 70
- Neutropenia and Cancer Infections 30
- Co-authors
- Felicitas R. Thol (78 shared papers)Bernd Hertenstein (54 shared papers)Michael Heuser (105 shared papers)Jürgen Krauter (80 shared papers)Gerhard Heil (68 shared papers)Hartmut Doehner (75 shared papers)Brigitte Schlegelberger (66 shared papers)Matthias Eder (80 shared papers)
- Journals
- Blood (239 papers)Annals of Hematology (77 papers)Leukemia (61 papers)Bone Marrow Transplantation (35 papers)British Journal of Haematology (33 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Arnold Ganser
962 papers receiving 48.9k citations
Arnold Ganser's Hit Papers
Peers
Comparison fields: 5 of 172
- Hematology 28.6k
- Genetics 4k
- Oncology 3.3k
- Cancer Research 1.6k
- Immunology 1.9k
Countries citing papers authored by Arnold Ganser
This map shows the geographic impact of Arnold Ganser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnold Ganser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnold Ganser more than expected).
Fields of papers citing papers by Arnold Ganser
This network shows the impact of papers produced by Arnold Ganser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnold Ganser. The network helps show where Arnold Ganser may publish in the future.
Co-authors
The 25 scholars most cited alongside Arnold Ganser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 995 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genomic Classification and Prognosis in Acute Myeloid Leukemia Hit paper breakdown → | 2016 | 3373 |
| 2 | Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation Hit paper breakdown → | 2017 | 1804 |
| 3 | Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Hit paper breakdown → | 2004 | 1761 |
| 4 | Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia Hit paper breakdown → | 2008 | 1357 |
| 5 | Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia Hit paper breakdown → | 2013 | 1275 |
| 6 | Intracoronary Bone Marrow Cell Transfer After Myocardial Infarction Hit paper breakdown → | 2006 | 794 |
| 7 | 2005 | 782 | |
| 8 | Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma Hit paper breakdown → | 2010 | 701 |
| 9 | TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome Hit paper breakdown → | 2011 | 566 |
| 10 | Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults Hit paper breakdown → | 1988 | 490 |
| 11 | Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group Hit paper breakdown → | 2011 | 475 |
| 12 | Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease Hit paper breakdown → | 2010 | 454 |
| 13 | Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study Hit paper breakdown → | 2009 | 419 |
| 14 | Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies Hit paper breakdown → | 2012 | 415 |
| 15 | 2011 | 412 | |
| 16 | 2011 | 398 | |
| 17 | 2010 | 395 | |
| 18 | 2012 | 369 | |
| 19 | 2006 | 366 | |
| 20 | 2011 | 348 |
About Arnold Ganser
Arnold Ganser is a scholar working on Hematology, Oncology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 995 papers that have together received 50.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (413 papers), Hematopoietic Stem Cell Transplantation (209 papers), Acute Lymphoblastic Leukemia research (40 papers), Chronic Myeloid Leukemia Treatments (33 papers), Retinoids in leukemia and cellular processes (30 papers), Neutropenia and Cancer Infections (30 papers), Renal cell carcinoma treatment (25 papers) and Lymphoma Diagnosis and Treatment (25 papers). The work is most often cited by research in Hematology (28.6k citations), Genetics (4k citations), Oncology (3.3k citations), Cancer Research (1.6k citations) and Immunology (1.9k citations). Arnold Ganser has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Felicitas R. Thol, Bernd Hertenstein, Michael Heuser, Jürgen Krauter, Gerhard Heil, Hartmut Doehner, Brigitte Schlegelberger, Matthias Eder, Richard F. Schlenk and Kai Christoph Wollert. Their work appears in journals such as Blood, Annals of Hematology, Leukemia, Bone Marrow Transplantation and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.